Tech Company Financing Transactions
Sigrid Therapeutics Funding Round
Sigrid Therapeutics, based in Stockholm, secured $4 million from private investors.
Transaction Overview
Company Name
Announced On
10/31/2023
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will be instrumental in accelerating the commercialisation of SiPore® across diverse markets, including medical devices, food supplements, veterinary, and oral health.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7A Odenplan Norrtullsgatan 6, Plan 5
Stockholm, 113 29
SE
Stockholm, 113 29
SE
Phone
Website
Email Address
Overview
Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sana Alajmovic
Chief Technical Officer
Eric Johnston
Co-Founder
Tore Bengtsson
Browse more venture capital transactions:
Prev: 10/31/2023: Neteera venture capital transaction
Next: 10/31/2023: FounderSix venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs